GLPG-0259

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGLPG-0259
Drug Alias NameGLPG 0259GT-418GLPG0259
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMAP kinase-activated protein kinase 5 inhibitors
TargetsMAP kinase-activated protein kinase 5
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUkrainePoland +[5] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGalapagos Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGalapagos Nv
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A